Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)
Vik Atopic Dermatitis continues its expansion across the world! 🚀 It’s been launched in 3 more countries: the United Arab Emirates, the Kingdom of Saudi Arabia, and Brazil!
This marks a new milestone for our virtual companion as it makes its debut in the Greater Gulf. We are proud of Vik, for pushing boundaries and opening frontiers for patient empowerment.
Developed with the support of patients, associations, and healthcare professionals, Vik AD:
☝️ Provides answers to all questions 24/7
🗣 Shares tips, daily inspiration, and patient testimonials
⏰ Helps patients monitor their illness (such as symptoms, treatment, appointment reminders, etc.).
You can download it here: https://lnkd.in/eHTFP72b
👏Congratulations to the Wefighters working on this project:
Philippe Fernandes, PhD, Gwendolyn Jauffret, Emma Rousseau, Lucas Tidas, Tristan Voiron, Antonin VAL, Olman Hidalgo Muñoz, Halim El khoury, Andressa Arabe
After taking Vik Atopic Dermatitis to 9 countries and in four different languages, our main goal remains guiding patients through their search for a healthier life.
Telemedicine at the service of patients 🚀
We’re proud to announce a partnership with TeleClinic, Germany’s market leader for online consultations.
We are proud to announce the launch of Vik Colorectal in Spain! Developed with the institutional support of Pierre Fabre Group, our newest virtual companion will support patients and their loved ones living with colorectal cancer!
It’s with great pleasure that we announce our partnership with Maiia, an e-health solution powered by Cegedim Santé! 💪 Bringing to you the news today, Benoit Brouard, founder and CEO of Wefight, and Victor Jobin, Partnerships Director at Maiia.